MF
LGND icon

Magnetar Financial’s Ligand Pharmaceuticals LGND Stock Holding History

Magnetar Financial’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-4,883
Closed -$290K – 820
2020
Q3 		$290K Buy
+4,883
New +$333K 0.01% 543
2017
Q3 		– Sell
-2,655
Closed -$201K – 815
2017
Q2 		$201K Buy
+2,655
New +$186K ﹤0.01% 695
2015
Q3 		– Sell
-7,887
Closed -$496K – 467
2015
Q2 		$496K Buy
+7,887
New +$430K 0.01% 236

Other funds holding LGND

William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return

Magnetar Financial's LGND Position: Q4 2020 in Review

Magnetar Financial sold out of Ligand Pharmaceuticals (LGND) in Q4 2020, closing a stake of 4,883 shares — an estimated $290K sold.

Magnetar Financial first reported a position in LGND in Q2 2015 and held it in 3 quarters. The position peaked at $496K in Q2 2015. 242 funds tracked by Wall St. Rank hold LGND as of Q4 2020.

  • Magnetar Financial reported no remaining Ligand Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Magnetar Financial sold 4,883 Ligand Pharmaceuticals shares in Q4 2020, an estimated $290K.
  • Magnetar Financial first reported a position in Ligand Pharmaceuticals in Q2 2015 and held it in 3 quarters.
  • Magnetar Financial's Ligand Pharmaceuticals position peaked at $496K in Q2 2015.
  • 242 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q4 2020.

Based on Magnetar Financial's 13F filing for Q4 2020, filed 12 Feb 2021.